HTML
-
One of the well-known independent risk factors for type 2 diabetes is fasting plasma glucose (FPG)[1], which may also increase the risk of cardiovascular disease (CVD)[2-4]. In recent years, epidemiological evidence has supported the idea that toxic heavy metals, including cobalt, arsenic, selenium, cadmium, iron, and copper, are associated with the prevalence of CVD[5-8]. In fact, some metals can persist in the living and working environment for several years, and some heavy metals (such as nickel, cadmium, arsenic, and argentum) even have biological half-lives of more than several years[9-11], which makes them a public health concern. Nevertheless, evidence for the association of heavy metals with diabetes or FPG is still limited or due to controversies.
Son et al.[12] found environmental exposure to cadmium in abandoned mine residents to be associated with diabetes. Barregard et al.[13] also found a significant interaction between high concentrations of blood cadmium (B-Cd) and diabetes mellitus (DM), providing support for the hypothesis that adults with DM have a higher risk of renal glomerular damage from cadmium exposure than those without DM. Shapiro et al.[14] observed dose-response relationships between four metals (lead, cadmium, mercury, and arsenic) and the incidence of gestational diabetes mellitus (GDM), only plasma arsenic levels displayed a significant association with GDM, but no statistically significant associations were observed between cadmium and GDM. A significant association was observed between cerebrovascular disease (CCVD) and urinary cobalt in a previous study in the USA[5], but in a study investigating the risk of diabetes and prediabetes among occupational workers, higher levels of urinary cobalt was associated with an increased risk of diabetes in male subjects only. Moreover, their research also uncovered significant associations between nickel, copper, and diabetes. Many of the above-mentioned chemicals are used extensively in everyday consumer products and are ubiquitous in our living environment. However, there are limited epidemiologic data regarding the risk of metabolic dysfunction associated with metal element exposure and a variety of metal levels in the blood of the Han Chinese population. Consequently, more studies are needed to confirm the observed associations and explore new findings.
Based on the above background information, we aimed to explore the associations of type 2 diabetes risk with the plasma levels of 20 trace elements as well as heavy metals in the present study, including vanadium, manganese, iron, chromium, cobalt, copper, nickel, zinc, arsenic, selenium, rubidium, strontium, ruthenium, rhodium, palladium, argentum, cadmium, cesium, barium, and lanthanum, among 551 Han Chinese adults recruited from a community physical examination clinic in Suzhou, Jiangsu Province, China.
-
The subjects in our study were examined and recruited between April 2014 and July 2016. The source population consisted of community residents in Suzhou City. We selected both cases and controls from the same City for the reason of more similar living environment and dietary habits comparing to different cities, which may be confounders for type 2 diabetes.
The diagnostic criteria for new cases of diabetes were based on blood glucose levels, defined as random plasma glucose concentrations ≥ 11.1 mmol/L plus symptoms of diabetes, 2-hour post-load oral glucose tolerance test (OGTT) ≥ 11.1 mmol/L, or fasting plasma glucose (FPG) ≥ 7.0 mmol/L. In addition, an HbA1c ≥ 6.5% has been accepted as a diagnostic criterion for DM. Adults who were selected as newly diagnosed cases should not have been previously diagnosed with type 2 diabetes by a physician and should not be current or past users of any oral hypoglycemic drugs or insulin. However, the definitions of newly diagnosed diabetes were determined after professional medical discussions with learned and experienced endocrinologists from the physical examination center.
Each subject donated 5-mL venous blood samples for subsequent blood testing. FPG was assayed with an automated biochemical analyzer (Randox Laboratories Ltd., UK) using the enzymatic colorimetric method. Clinical laboratory technicians working in Nanjing Prevention and Treatment Center for Occupational Diseases carried out the experiment according to standard operation procedures.
-
Subject information was collected via questionnaire administered by trained interviewers in the form of face-to-face interviews. The questionnaire generally included demographic data, past and present medical conditions, pharmaceutical preparations, physical activity and diet during daily life, hereditary factors, drinking status, and smoking and passive smoking status. In our study, ever drinkers were identified as subjects who drank a bottle of beer or 50 g of wine per day for at least one year, and everyone else was classified as a never drinker. Workers who had one cigarette per day for at least one year were identified as ever smokers, and all others were never smokers.
-
In the first round of selection, subjects who had been diagnosed with diabetes by professional endocrinologists and had being undergoing treatment or taking medication previously or presently were excluded from our study, as we sought newly diagnosed patients who had never undergone therapeutic treatment.
For the following analyses, we excluded subjects with missing blood samples, missing blood glucose data, or abnormal blood biochemical levels, which would probably have resulted in abnormal plasma outputs of metal elements. Adults whose blood did not qualify for plasma detection were also excluded. In addition, we excluded participants with missing investigative or physical examination data (e.g., missing height, weight, systolic or diastolic pressure, smoking or drinking status, total cholesterol or triglycerides, etc.).
Each recruited newly diagnosed case of type 2 diabetes was well matched with 1-4 controls. The cases were selected without any restriction on age or sex, while the controls, which were frequency-matched to the cases by age, gender, and BMI, consisted of individuals from the same community who were seeking health care from the Suzhou Center for Disease Control and Prevention at the same time. The final participant population consisted of 551 subjects (122 newly diagnosed cases of type 2 diabetes and 429 matched controls) from a community physical examination center in Suzhou city of Jiangsu Province, China.
-
This project was approved by the Ethics Committee of Nanjing Medical University. Written informed consent was obtained from each individual. Ethical guidelines were followed throughout the whole study period.
-
We determined the concentrations of 20 metals in plasma in the following steps. In brief, the frozen plasma samples were stored in a refrigerator at 5 ℃ 3 h before sample preparation and completely thawed at room temperature immediately before the experiment, followed by homogenizing on a vortex mixer. A 200-μL plasma sample was pipetted into a 10-mL centrifuge tube (LabServ. Thermo Fisher Scientific, USA) containing 200 μL of 100-μg/L interior label, and then the volume was adjusted to 4.0 mL with diluent prepared with 65% (v/v) highly purified Triton X-100 (Sigma-Aldrich), 65% nitric acid HNO3 (Merck KGaA, Germany), and purified water (Wahaha Purified Water, China). When the final homogenization was complete, we measured metal concentrations in the composite samples with an inductively-coupled plasma mass spectrometer on the basis of an octupole-based collision/reaction cell (Thermo, iCAP-Q ICP-MS, USA). Furthermore, internal quality control samples with every batch were detected after standardization. The detection limits of all metal elements are demonstrated in Table 1.
Elements Detection Limits (μg/L) Vanadium 0.0040 Chromium 0.0153 Manganese 0.0213 Iron 0.4043 Cobalt 0.0015 Nickel 0.0540 Copper 0.0329 Zinc 0.3189 Arsenic 0.0181 Selenium 0.0000 Rubidium 0.0234 Strontium 0.0435 Ruthenium 0.0019 Rhodium 0.0002 Palladium 0.0073 Argentum 0.0054 Cadmium 0.0023 Cesium 0.0016 Barium 0.0642 Lanthanum 0.0011 Table 1. Detection Limits of ICP-MS for Metal Elements
-
Measurement data are expressed as mean ± SD (x±s), and data with a skewed distribution are described as median and interquartile ranges. Differences among groups were analyzed by nonparametric tests, student t-test, or one-way ANOVA. Qualitative data were described as percentages and analyzed using the chi-square (χ2) test or Fisher's exact test as indicated. Crude and adjusted odds ratios (ORs) were determined with 95% confidence intervals (95% CIs) by multivariate logistic regression.
Results were considered statistically significant at P < 0.05. We entered all data into a computerized database using the statistical analysis software Epidata 3.1. All analyses were performed using the SPSS software (Version 22.0, SPSS Inc., USA) and SAS 9.1.3 (SAS Institute, Cary, NC).
Study Participations
Questionnaire
Exclusion Criteria
Ethical Consideration
Detection of Plasma Metal Contents
Statistical Analysis
-
Table 2 shows the basic characteristics of all subjects. A total of 551 participants were analyzed in this study. There were more female subjects than male ones in each group and in the total population. Approximately 216 (39.2%) out of 551 subjects were male, whereas the remaining 335 (60.8%) were female. The age range of all subjects was 40-92, and the mean age was 66.48, 66.25, and 66.43 years for controls, newly diagnosed type 2 diabetes patients, and the total population, respectively. Most of our population disapproved of smoking and drinking: 84.0% of study subjects were never smokers, and 16.0% were ever smokers. The ratio of never to ever drinkers was 89.7% and 10.3%, respectively. There were no significant differences between cases and controls with respect to age, gender, BMI, and smoking status; however, cases were more likely than controls to be ever drinkers. The percentage of current drinkers in cases was significantly higher than in controls (15.6% vs. 8.9%, P < 0.05). With respect to family history, the case group was more likely to have a family history of diabetes than the controls, with a prevalence of 14.8% in cases and 4.7% in controls. However, the mean level of FPG in newly diagnosed diabetes was significantly higher than that in controls (7.55 vs. 5.67 mmol/L, P < 0.05).
Variables All (N = 551) Cases (N = 122) Controls (N = 429) P Gender, n (%) Male 216 (39.2) 43 (35.2) 173 (40.3) 0.310a Female 335 (60.8) 79 (64.8) 256 (59.7) Age, years 66.43 ± 9.36 66.25 ± 9.46 66.48 ± 9.34 0.809b < 66, n (%) 234 (42.5) 55 (45.1) 179 (41.7) 0.880a 66-70, n (%) 136 (24.7) 25 (20.5) 111 (25.9) > 70, n (%) 181 (32.8) 42 (34.4) 139 (32.4) BMI, kg/m2 24.67 ± 3.32 25.08 ± 3.74 24.55 ± 3.18 0.151b Smoking status, n (%) Never 463 (84.0) 100 (82.0) 363 (84.6) 0.481a Ever 88 (16.0) 22 (18.0) 66 (15.4) Drinking status, n (%) Never 494 (89.7) 103 (84.4) 391 (91.1) 0.032a Ever 57 (10.3) 19 (15.6) 38 (8.9) Family history, n (%) No 513 (93.1) 104 (85.2) 409 (95.3) 0.000a Yes 38 (6.9) 18 (14.8) 20 (4.7) FPG, mmol/L 6.09 ± 3.18 7.55 ± 2.14 5.67 ± 3.30 0.000b Note. aχ2 test for the distribution between cases and controls. bStudent t-test for mean comparison between cases and controls. Table 2. Descriptive Characteristics of New Diagnosed Cases of Type 2 Diabetes and Controls
-
Table 3 shows the blood levels of 20 metal elements in our study participants. There were significant differences between cases and controls in plasma vanadium concentration: the median concentration of vanadium was 0.234 μg/L in the case group and 0.177 μg/L in the control group (P < 0.05). Similarly, blood levels of chromium, manganese, copper, zinc, and cadmium were higher in cases than those in controls (P < 0.05): the corresponding concentrations were 2.286 μg/L in cases vs. 1.898 μg/L in controls for chromium, 2.725 μg/L vs. 1.828 μg/L for manganese, 932.164 μg/L vs. 786.388 μg/L for copper, 634.382 μg/L vs. 575.205 μg/L for zinc, and 0.096 μg/L vs. 0.065 μg/L for cadmium. Participants with diabetes had significantly higher concentrations of arsenic, selenium, strontium, palladium, cesium, and barium than those in the non-diabetic group (P < 0.05): their comparative plasma levels were 0.754 μg/L in diabetes vs. 0.536 μg/L in non-diabetes for arsenic, 18.565 μg/L vs. 15.447 μg/L for selenium, 33.248 μg/L vs. 30.539 μg/L for strontium, 0.373 μg/L vs. 0.231 μg/L for palladium, 0.957 μg/L vs. 0.779 μg/L for cesium, and 8.173 μg/L vs. 4.802 μg/L for barium. However, there was no significant difference in the blood concentrations of iron, cobalt, nickel, rubidium, ruthenium, rhodium, argentum, and lanthanum between cases and controls with respect to the median values.
Variables All Cases Controls Pa Median
(μg/L)Quartile Range
(μg/L)Median
(μg/L)Quartile Range
(μg/L)Median
(μg/L)Quartile Range
(μg/L)Vanadium 0.191 0.138 0.234 0.180 0.177 0.125 0.000 Chromium 1.952 1.114 2.286 1.389 1.898 1.048 0.000 Manganese 1.954 1.242 2.725 1.930 1.828 0.944 0.000 Iron 1117.162 451.861 1174.648 459.733 1104.439 442.876 0.139 Cobalt 0.294 0.124 0.292 0.132 0.297 0.122 0.563 Nickel 6.478 3.640 5.968 3.903 6.551 3.570 0.191 Copper 815.755 261.226 932.164 268.340 786.388 244.672 0.000 Zinc 590.108 196.973 634.382 191.369 575.205 201.633 0.000 Arsenic 0.615 0.784 0.754 0.584 0.536 0.790 0.002 Selenium 16.390 11.875 18.565 9.279 15.447 12.538 0.000 Rubidium 277.661 82.564 274.967 66.249 278.579 93.801 0.501 Strontium 31.456 12.724 33.248 14.153 30.539 11.489 0.000 Ruthenium 0.043 0.061 0.046 0.069 0.042 0.057 0.398 Rhodium 0.000 0.003 0.000 0.003 0.000 0.003 0.545 Palladium 0.287 0.716 0.373 0.609 0.231 0.693 0.002 Argentum 0.411 0.462 0.503 0.398 0.390 0.497 0.730 Cadmium 0.071 0.065 0.096 0.102 0.065 0.061 0.000 Cesium 0.821 0.404 0.957 0.375 0.779 0.382 0.000 Barium 5.115 4.633 8.173 13.656 4.802 3.202 0.000 Lanthanum 0.035 0.034 0.038 0.032 0.035 0.036 0.333 Note. aNonparametric test for the comparison of metal levels in abnormal distribution. Table 3. Metal Concentrations in New Diagnosed Diabetes and Controls
-
We divided the subjects' plasma metal concentrations into tertiles to analyze the association between diabetes prevalence and metal content. Serum iron, cobalt, nickel, rubidium, ruthenium, rhodium, argentum, and lanthanum were not associated with diabetes risk (Table 4). However, for the other metals, we observed statistically significant correlations with increased diabetes risk. After adjusting for confounders, the adjusted OR values and 95% CI of diabetes of the third tertiles (the highest group) comparing minimum tertiles (the lowest group) for vanadium, chromium, manganese, copper, zinc, arsenic, selenium, strontium, palladium, cadmium, cesium, and barium were 3.589 (2.040-6.314), 2.219 (1.319-3.733), 7.880 (4.169-14.893), 6.862 (3.644-12.920), 2.261 (1.285-3.979), 2.204 (1.244-3.905), 6.138 (3.012-12.509), 2.151 (1.273-3.636), 2.236 (1.266-3.952), 2.511 (1.486-4.245), 3.908 (2.223-6.869), and 6.184 (3.448-11.093), respectively, and the second tertiles (the middle group) comparing minimum tertiles for vanadium, manganese, copper, zinc, arsenic, selenium, palladium, and cesium were 2.100 (1.178-3.744), 2.528 (1.286-4.969), 2.796 (1.456-5.368), 1.964 (1.132-3.407), 3.436 (1.956-6.037), 8.134 (4.088-16.182), 2.409 (1.370-4.237), and 1.847 (1.015-3.361), respectively. Furthermore, the adjusted OR increased with increasing concentration of vanadium, manganese, copper, zinc, and cesium per tertile (P < 0.05).
Variables Q1 (lowest)
(μg/L)Q2 (middle)
(μg/L)Q3 (highest)
(μg/L)Pb Vanadium < 0.151 0.151- 0.235 Case: N (%) 22 (18.03) 40 (32.79) 60 (49.18) 0.000 Control: N (%) 162 (37.76) 143 (33.33) 124 (28.91) All (%) 184 (33.39) 183 (33.22) 184 (33.39) Adjusted OR (95% CIs)a 1.000 2.100 (1.178-3.744) 3.589 (2.040-6.314) Chromium < 1.623 1.623-2.321 > 2.321 Case: N (%) 30 (24.59) 33 (27.05) 59 (48.36) 0.000 Control: N (%) 152 (35.43) 151 (35.20) 126 (29.37) All (%) 182 (33.03) 184 (33.39) 185 (33.58) Adjusted OR (95% CIs)a 1.000 1.066 (0.605-1.878) 2.219 (1.319-3.733) Manganese < 1.671 1.671-2.416 > 2.416 Case: N (%) 14 (11.48) 33 (27.05) 75 (61.47) 0.000 Control: N (%) 169 (39.39) 152 (35.43) 108 (25.18) All (%) 183 (33.21) 185 (33.58) 183 (33.21) Adjusted OR (95% CIs)a 1.000 2.528 (1.286-4.969) 7.880 (4.169-14.893) Iron < 988.245 988.245-1293.406 > 1293.406 Case: N (%) 34 (27.87) 45 (36.89) 43 (35.24) 0.246 Control: N (%) 150 (34.97) 139 (32.40) 140 (32.63) All (%) 184 (33.39) 184 (33.39) 183 (33.22) Adjusted OR (95% CIs)a 1.000 1.418 (0.847-2.373) 1.591(0.900-2.814) Cobalt < 0.259 0.259-0.340 > 0.340 Case: N (%) 45 (36.89) 38 (31.15) 39 (31.96) 0.520 Control: N (%) 140 (32.63) 147 (34.27) 142 (33.10) All (%) 185 (33.58) 185 (33.58) 181 (32.84) Adjusted OR (95% CIs)a 1.000 0.820 (0.495-1.357) 0.822 (0.496-1.364) Nickel < 5.365 5.365-7.713 > 7.713 Case: N (%) 53 (43.44) 30 (24.59) 39 (31.97) 0.074 Control: N (%) 130 (30.30) 154 (35.90) 145 (33.80) All (%) 183 (33.22) 184 (33.39) 184 (33.39) Adjusted OR (95% CIs)a 1.000 0.416 (0.245-0.706) 0.637 (0.383-1.060) Copper < 729.661 729.661-901.400 > 901.400 Case: N (%) 15 (12.30) 37 (30.32) 70 (57.38) 0.000 Control: N (%) 168 (39.16) 147 (34.27) 114 (26.57) All (%) 183 (33.22) 184 (33.39) 184 (33.39) Adjusted OR (95% CIs)a 1.000 2.796 (1.456-5.368) 6.862 (3.644-12.920) Zinc < 529.777 529.777-649.232 > 649.232 Case: N (%) 27 (22.13) 43 (35.25) 52 (42.62) 0.002 Control: N (%) 156 (36.36) 141 (32.87) 132 (30.77) All (%) 183 (33.22) 184 (33.39) 184 (33.39) Adjusted OR (95% CIs)a 1.000 1.964 (1.132-3.407) 2.261 (1.285-3.979) Arsenic < 0.389 0.389-0.915 > 0.915 Case: N (%) 22 (18.03) 57 (46.72) 43 (35.25) 0.008 Control: N (%) 162 (37.76) 127 (29.60) 140 (32.64) All (%) 184 (33.39) 184 (33.39) 183 (33.22) Adjusted OR (95% CIs)a 1.000 3.436 (1.956-6.037) 2.204 (1.244-3.905) Selenium < 12.774 12.774-19.825 > 19.825 Case: N (%) 13 (10.66) 60 (49.18) 49 (40.16) 0.000 Control: N (%) 171 (39.86) 124 (28.90) 134 (31.24) All (%) 184 (33.39) 184 (33.39) 183 (33.22) Adjusted OR (95% CIs)a 1.000 8.134 (4.088-16.182) 6.138 (3.012-12.509) Rubidium < 251.164 251.164-300.669 > 300.669 Case: N (%) 32 (26.23) 54 (44.26) 36 (29.51) 0.615 Control: N (%) 152 (35.43) 129 (30.07) 148 (34.50) All (%) 184 (33.39) 183 (33.22) 184 (33.39) Adjusted OR (95% CIs)a 1.000 2.286 (1.354-3.860) 1.057 (0.578-1.933) Strontium < 28.225 28.225-36.059 > 36.059 Case: N (%) 28 (22.95) 40 (32.79) 54 (44.26) 0.001 Control: N (%) 156 (36.36) 144 (33.57) 129 (30.07) All (%) 184 (33.39) 184 (33.39) 183 (33.22) Adjusted OR (95% CIs)a 1.000 1.505 (0.866-2.616) 2.151 (1.273-3.636) Ruthenium < 0.027 0.027-0.065 > 0.065 Case: N (%) 34 (27.87) 45 (36.89) 43 (35.24) 0.246 Control: N (%) 150 (34.97) 139 (32.40) 140 (32.63) All (%) 184 (33.39) 184 (33.39) 183 (33.22) Adjusted OR (95% CIs)a 1.000 1.349 (0.803-2.267) 1.277 (0.749-2.179) Rhodium < 0.000 0.000-0.003 > 0.003 Case: N (%) 64 (52.46) 37 (30.33) 21 (17.21) 0.286 Control: N (%) 227 (52.91) 87 (20.28) 115 (26.81) All (%) 291 (52.81) 124 (22.50) 136 (24.69) Adjusted OR (95% CIs)a 1.000 1.568 (0.962-2.557) 0.686 (0.394-1.194) Palladium < 0.100 0.100-0.493 > 0.493 Case: N (%) 23 (18.85) 53 (43.44) 46 (37.71) 0.004 Control: N (%) 160 (37.30) 131 (30.54) 138 (32.16) All (%) 183 (33.22) 184 (33.39) 184 (33.39) Adjusted OR (95% CIs)a 1.000 2.409 (1.370-4.237) 2.236 (1.266-3.952) Argentum < 0.300 0.300-0.636 > 0.636 Case: N (%) 36 (29.51) 48 (39.34) 38 (31.15) 0.801 Control: N (%) 147 (34.27) 137 (31.93) 145 (33.80) All (%) 183 (33.21) 185 (33.58) 183 (33.21) Adjusted OR (95% CIs)a 1.000 1.458 (0.870-2.442) 0.929 (0.544-1.587) Cadmium < 0.051 0.051-0.096 > 0.096 Case: N (%) 28 (22.95) 33 (27.05) 61 (50.00) 0.000 Control: N (%) 153 (35.66) 152 (35.43) 124 (28.91) All (%) 181 (32.84) 185 (33.58) 185 (33.58) Adjusted OR (95% CIs)a 1.000 1.086 (0.617-1.912) 2.511 (1.486-4.245) Cesium < 0.700 0.700-0.951 > 0.951 Case: N (%) 21 (17.21) 37 (30.33) 64 (52.46) 0.000 Control: N (%) 163 (38.00) 147 (34.27) 119 (27.73) All (%) 184 (33.39) 184 (33.39) 183 (33.22) Adjusted OR (95% CIs)a 1.000 1.847 (1.015-3.361) 3.908 (2.223-6.869) Barium < 4.134 4.134-6.786 > 6.786 Case: N (%) 18 (14.75) 28 (22.95) 76 (62.30) 0.000 Control: N (%) 165 (38.46) 157 (36.60) 107 (24.94) All (%) 183 (33.21) 185 (33.58) 183 (33.21) Adjusted OR (95% CIs)a 1.000 1.583 (0.823-3.046) 6.184 (3.448-11.093) Lanthanum < 0.026 0.026-0.049 > 0.049 Case: N (%) 36 (29.50) 43 (35.25) 43 (35.25) 0.379 Control: N (%) 148 (34.50) 140 (32.63) 141 (32.87) All (%) 184 (33.39) 183 (33.22) 184 (33.39) Adjusted OR (95% CIs)a 1.000 1.236 (0.741-2.062) 1.202 (0.712-2.029) Note. aAdjusted for age, gender, BMI, family history, smoking and drinking status in the logistic regression model. bχ2 test for the distribution of different metal levels. Table 4. Comparisons of Diabetes risk According to the Three Tertiles of Plasma Metals
Basic Participant Characteristics
Plasma Metal Levels in Cases and Controls
Plasma Metals and Diabetes
-
The present study suggests that newly diagnosed diabetes patients were more likely to be drinkers and to have higher average blood concentrations of some metals (vanadium, chromium, manganese, copper, zinc, arsenic, selenium, strontium, palladium, cadmium, cesium, and barium) than control subjects without type 2 diabetes. This indicates that drinking may induce pancreatic β-cell dysfunction or an inability to produce insulin, which plays an important role in decreasing blood glucose. In previous studies, some metals (arsenic, cadmium, manganese, zinc, and mercury) are thought to have estrogenic activity and are consequently classified as EDCs (environmental endocrine disruptors)[15-18]. They can simulate some features of insulin secreted from pancreatic β-cells, disturbing normal insulin regulatory function with blood glucose and causing pathoglycemia or even more serious illness.
The plasma concentration results of heavy metals in this study are in partial agreement with those of a previous population-based study exploring the association of urinary metal profiles with diabetes risk[19-21]. However, it must be kept in mind that, in our research, we decided a priori to use metals in the blood rather than in the urine as the main outcome measure of metal burden, because there is diurnal variability in metal excretion, which is usually affected by urinary flow rate[22]. Therefore, the variability of metal levels in urine is substantial, despite their long half-lives. Taking this into account, urinary metals are not good biomarkers for many outcomes, because the excretion of metals varies far more due to other factors than to metal toxicity itself. Fortunately, blood metal levels were used in our study as a valid biomarker, which is not affected by the above factors, because metal levels in blood are steady unless individuals change their diet or living habits dramatically.
We did not find significant differences in palsma nickel concentration between the third and first tertiles, but the nickel level in the middle tertile was the protective factor against diabetes in the present study. Although it has been reported that the whole-body burden of nickel might be changed in diabetes, the results were inconsistent. Kazi et al.[23] showed no difference in blood levels of nickel between patients with diabetes and controls, whereas some other findings reported a higher concentration of plasma nickel in diabetics[24-28]. However, Yarat et al.[29] found a lower serum nickel concentration in patients with diabetes. A significant association between plasma arsenic and diabetes has been found in our study, which was in line with previous studies[30-33]. Some researchers with human and animal experimental evidence suggested that arsenic may impair pancreatic β-cells in the process of insulin synthesis and secretion, decreasing glucose uptake[34-37]. Skalnaya et al.[38] have evaluated serum levels of copper, zinc, and iron in diabetes patients. Our results also showed that elevated plasma copper and zinc levels were significantly correlated with increased diabetes risk. Unfortunately, we did not find iron to be associated with diabetes risk among subjects, which may suggest that current intake levels of iron may not affect the glucose metabolism. Our results showed that elevated plasma selenium levels were significantly correlated with increased diabetes risk; however, there was conflicting evidence linking selenium to glucose metabolism. Askari[39] suggest that blood Selenium concentration is significantly lower in patients with hyperglycemia than in those with euglycemia. In agreement with their results, high selenium status was associated with reduced diabetes prevalence in several prospective studies[40-42]. However, high serum and plasma selenium concentrations were associated with an increased prevalence of diabetes in other studies[43-46], and a non-significant association has also been found[47-49]. Our results also suggested that plasma cadmium was related to diabetes, which was in accordance with previous studies indicating that cadmium could cause diabetes through disruption of pancreatic β-cells and the presence of oxidative stress[50-52].
The present study has a number of strengths and limitations. The case group consists of newly diagnosed diabetes, and the diagnosis of type 2 diabetes was based on the professional medical opinions of endocrinologists from the physical examination center. Moreover, we focus on the metal concentrations in plasma and not in urine, a result that is easily affected by urinary flow rate. Regarding limitations, it should firstly be noted that this was a cross-sectional study, so we do not know whether diabetes results from the presence of these metals in the body or vice versa, because the cross-sectional design is a limitation regarding causality. Furthermore, the limited size of the final population (122 newly diagnosed cases of type 2 diabetes and 429 matched controls) is also a limitation. Finally, we cannot exclude the possibility of a false-positive result, because our results were obtained only as the plasma output of these metals; thus, the positive findings regarding metal levels and diabetes may have been due to chance. Therefore, the associations found in this study require further investigation in future studies.
Our results emphasized the need to monitor environmental metal levels in order to reduce metal exposure to humans. Further research is urgently needed to determine the role of metals in the development of diabetes.
-
We thank all subjects who participated in this study and the Suzhou Biobank.
-
The authors have no conflicts of interest to declare.